HOLLYWOOD, Calif., Nov. 2, 2012 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) (www.medboxinc.com) announced that they have increased their shareholder base last quarter by over 30%. The announcement comes at a time of significant additions to the company's product line, as well the launch of a new division dedicated to serving the healthcare and pharmaceutical industries.
The new shareholders have come on board at an opportune time - before the company's planned move up from the Pink Sheets to the OTC Bulletin Board. As part of this process, the company is in the midst of an audit in order to comply with the fully reporting standards set forth by the SEC.
In addition, the company has reported a record setting 3rd quarter, generating over $1.3 million in revenue and its highest EBITDA margin to date.
"We are thrilled to have so many new people join our family of shareholders," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "With our lineup of exciting new products, solid revenue growth, and specialized divisions to target specific industry sectors, it is no wonder that people from all over the world are starting to invest with our company."
In the coming months Medbox will be announcing exciting dividend programs for its shareholders upon the company meeting some of its performance goals. In addition, once the JOBS act is enacted by the SEC later this year, the company will be publicly announcing its plans to incentivize new accredited investors that acquire shares directly from the company.
For more information, contact Medbox Investor Relations at: (800) 762-1452.
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
|SOURCE Medbox, Inc.|
Copyright©2012 PR Newswire.
All rights reserved